- Home
- APT vs CUE Comparison
APT vs CUE Comparison
Compare APT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APT
- CUE
- Stock Information
- Founded
- APT 1983
- CUE 2014
- Country
- APT Canada
- CUE United States
- Employees
- APT N/A
- CUE N/A
- Industry
- APT
- CUE Biotechnology: Pharmaceutical Preparations
- Sector
- APT
- CUE Health Care
- Exchange
- APT Nasdaq
- CUE Nasdaq
- Market Cap
- APT 50.5M
- CUE 48.0M
- IPO Year
- APT 1995
- CUE 2018
- Fundamental
- Price
- APT $4.69
- CUE $0.78
- Analyst Decision
- APT
- CUE Strong Buy
- Analyst Count
- APT 0
- CUE 3
- Target Price
- APT N/A
- CUE $3.00
- AVG Volume (30 Days)
- APT 35.1K
- CUE 269.5K
- Earning Date
- APT 08-06-2025
- CUE 08-13-2025
- Dividend Yield
- APT N/A
- CUE N/A
- EPS Growth
- APT 2.28
- CUE N/A
- EPS
- APT 0.36
- CUE N/A
- Revenue
- APT $58,180,000.00
- CUE $7,991,000.00
- Revenue This Year
- APT N/A
- CUE N/A
- Revenue Next Year
- APT N/A
- CUE $23.84
- P/E Ratio
- APT $13.14
- CUE N/A
- Revenue Growth
- APT N/A
- CUE 13.83
- 52 Week Low
- APT $4.06
- CUE $0.45
- 52 Week High
- APT $6.44
- CUE $1.99
- Technical
- Relative Strength Index (RSI)
- APT 58.74
- CUE 58.42
- Support Level
- APT $4.69
- CUE $0.65
- Resistance Level
- APT $4.85
- CUE $0.88
- Average True Range (ATR)
- APT 0.15
- CUE 0.07
- MACD
- APT 0.02
- CUE 0.02
- Stochastic Oscillator
- APT 94.94
- CUE 63.74
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.